Found 9 matching trials
Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) PHASE1 The study is a prospective, single arm, non-randomized, open label pilot tr...
Show More Location
Multiple Locations
Learn More & Join Trial
Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma PHASE1 This will be a prospective, open label, single center, phase I lead-in stud...
Show More Location
Multiple Locations
Learn More & Join Trial
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma PHASE2 This study consists of 2 portions. The phase 2 portion is an open-label, si...
Show More Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Learn More & Join Trial
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) PHASE3 The study is a prospective, randomized controlled phase III trial aimed to ...
Show More Location
Arizona Oncology- Biltmore Cancer Center
Learn More & Join Trial
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma PHASE3 This is a multicenter, two-arm, randomized, double-blind, placebo-controlle...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM PHASE2 This is a prospective, open-label, single arm, historical control pilot stu...
Show More Location
Nemocnice Na Homolce
Learn More & Join Trial
Preoperative Preradiotherapy TTFields NA PreOperative PreRAdIotherapy Tumour Treating Fields (PORTRAIT) is a Phase I...
Show More Location
The Christie NHS Foundation Trust
Learn More & Join Trial
Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data N/A The goal of this observational study is to learn about the effectiveness of...
Show More Location
West China Hospital
Learn More & Join Trial
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer PHASE2 This is a multicenter, randomized, open-label study of Tumor Treating Field...
Show More Location
Central Alabama Research
Learn More & Join Trial